354 lines
13 KiB
Markdown
354 lines
13 KiB
Markdown
# AeThex IP Management & Governance Framework
|
|
|
|
## Executive Summary
|
|
|
|
The AeThex organizational structure implements a centralized IP holding company (IPCo) model where Labs acts as the IP owner, licensing proprietary technology to operational subsidiaries (Corp, Dev-Link) and the Foundation via formal agreements. This framework ensures clean IP ownership, maximizes valuation, manages tax efficiency through transfer pricing, and maintains compliance with related-party transaction rules.
|
|
|
|
## 1. Labs as IP Holding Company (IPCo)
|
|
|
|
All core intellectual property developed by Labs is owned by Labs, including:
|
|
|
|
- Patent portfolios (AI, algorithms, architectures)
|
|
- Software copyrights and source code
|
|
- Trade secrets and proprietary methodologies
|
|
- Trademarks and brand assets
|
|
|
|
**Benefits:**
|
|
|
|
- **Clean IP Title**: Consolidated, encumbrance-free IP ownership improves enterprise valuation
|
|
- **Protection**: IP separated from operational liabilities (Corp consulting disputes, Dev-Link platform issues)
|
|
- **Management**: Centralized IP portfolio administration across subsidiaries
|
|
- **Tax Efficiency**: Enables transfer pricing strategies and licensing revenue optimization
|
|
|
|
## 2. Labs → Corp: Commercial Licensing Agreement
|
|
|
|
### Commercial Technology License
|
|
|
|
Corp receives a Commercial License to "make and use" proprietary Lab technologies in commercial service delivery, specifically:
|
|
|
|
- Advanced AI models for game development optimization
|
|
- Custom algorithms for multiplayer architecture
|
|
- Tools and frameworks created through R&D
|
|
|
|
### Mechanics
|
|
|
|
- **Formal Written Agreement**: Mandatory documentation of rights, restrictions, and payment terms
|
|
- **Scope**: Right to integrate Labs IP into consulting deliverables and products for paying clients
|
|
- **Exclusivity**: Non-exclusive (Labs may license to Dev-Link or external parties)
|
|
- **Term**: Multi-year with renewal options
|
|
|
|
### Royalty Structure (Transfer Pricing)
|
|
|
|
Licensing fees from Corp to Labs must comply with the **Arm's Length Principle**—pricing comparable to unrelated companies in similar circumstances.
|
|
|
|
#### Value-Based Pricing Model
|
|
|
|
For unique intangibles (advanced AI), cost-plus pricing is insufficient. Instead:
|
|
|
|
1. **Economic Value Uplift**: Measure how Lab IP enables Corp to charge premium rates
|
|
|
|
- Example: If Lab AI enables Corp to charge 30% premium for specialized dev services, royalty should reflect that uplift
|
|
- Comparable: Industry benchmarks for AI licensing typically 15-25% of incremental revenue
|
|
|
|
2. **Benchmarking**: Document comparable third-party licensing rates for similar technologies
|
|
|
|
3. **Documentation**: Maintain detailed transfer pricing study with:
|
|
- Functional analysis (what each entity does)
|
|
- Economic analysis (value creation from IP)
|
|
- Comparable pricing analysis
|
|
- Selection of transfer pricing method
|
|
|
|
### Example Royalty Model
|
|
|
|
```
|
|
Labs AI licensing to Corp:
|
|
- 18-22% of gross revenue from projects using Lab IP
|
|
- Minimum annual royalty: $500K
|
|
- Quarterly true-up reconciliation
|
|
- Annually reviewed for market value updates
|
|
```
|
|
|
|
## 3. Labs → Dev-Link: Licensing for Platform Features
|
|
|
|
Dev-Link platform may license Lab IP for:
|
|
|
|
- AI-assisted candidate assessment and matching
|
|
- Specialized skill evaluation algorithms
|
|
- Predictive analytics for placement success
|
|
|
|
### Licensing Terms
|
|
|
|
- **Usage-Based**: Royalty per successful placement (SaaS unit economics)
|
|
- **Tiered**: Higher rates for higher-volume usage
|
|
- **Fair Market Value**: Tied to cost-per-acquisition (CAC) savings to recruiters
|
|
|
|
Example: If Lab AI reduces CAC by $500 per hire, royalty of $100-150 per placement is defensible.
|
|
|
|
## 4. Transfer Pricing for Intercompany Services
|
|
|
|
Beyond IP licensing, subsidiaries share services (HR, payroll, IT, accounting). All must be priced at Arm's Length.
|
|
|
|
### Routine Service Pricing (Simplified Cost-Based Method)
|
|
|
|
For routine administrative services, use **Simplified Cost-Based Method (SCM)**:
|
|
|
|
```
|
|
Charge = Actual Costs + Markup (typically 5-15%)
|
|
```
|
|
|
|
**Eligible Services:**
|
|
|
|
- HR administration, payroll processing
|
|
- IT infrastructure and support
|
|
- General accounting and bookkeeping
|
|
- Legal documentation review
|
|
|
|
**Requirements:**
|
|
|
|
- Clearly define which activities qualify
|
|
- Meticulously track direct costs
|
|
- Document markup selection (compare to similar service providers)
|
|
- Revisit annually for continued compliance
|
|
|
|
### Documentation
|
|
|
|
Maintain **Intercompany Service Agreement** including:
|
|
|
|
- Services provided
|
|
- Cost allocation methodology
|
|
- Markup rationale
|
|
- Annual cost reconciliation
|
|
|
|
## 5. Foundation-Related Transfers (Related-Party Safeguards)
|
|
|
|
The Foundation may receive services or assets from Corp/Dev-Link. **All must be at Fair Market Value (FMV)** to prevent private inurement and preserve 501(c)(3) status.
|
|
|
|
### Examples of Related-Party Transactions
|
|
|
|
1. **Corp provides office space to Foundation**
|
|
|
|
- Must charge Fair Market Rent (comparable leases in area)
|
|
- Document: Annual appraisal or comparable rent analysis
|
|
- Forbidden: Below-market lease = private inurement
|
|
|
|
2. **Corp donates curriculum materials to Foundation**
|
|
|
|
- Document as charitable contribution
|
|
- Fair value: Cost of development + reasonable markup
|
|
- Record in Foundation's fund accounting system
|
|
|
|
3. **Foundation leases servers from Corp**
|
|
- Must charge market-rate cloud infrastructure pricing
|
|
- Forbidden: Cost-based pricing (too favorable to Foundation)
|
|
- Analyze: AWS/GCP pricing for equivalent services
|
|
|
|
### Conflict of Interest Policy
|
|
|
|
Foundation must adopt and enforce a Conflict of Interest Policy including:
|
|
|
|
- Board members declare conflicts with related for-profit entities
|
|
- Disclosure of family/business relationships with Corp/Dev-Link executives
|
|
- Voting restrictions: Conflicted directors abstain on related-party votes
|
|
- Annual certification and review
|
|
|
|
**Key Rule**: Any director who derives financial benefit from transaction recuses themselves from approval.
|
|
|
|
## 6. Fair Market Value (FMV) Determination
|
|
|
|
### Methodology
|
|
|
|
**For Technology Licensing (Labs IP):**
|
|
|
|
- Comparable License Analysis (market rates for similar IP)
|
|
- Relief-from-Royalty (value of IP to users)
|
|
- Residual Profit Split (allocate profit between Lab innovation and operational execution)
|
|
|
|
**For Services:**
|
|
|
|
- Comparable Uncontrolled Price (market rates for same services)
|
|
- Cost-Plus Analysis (cost + reasonable markup)
|
|
- Resale Price Method (if service is resold externally)
|
|
|
|
### Documentation Requirements
|
|
|
|
For each significant related-party transaction:
|
|
|
|
```
|
|
- Description of transaction
|
|
- FMV determination method used
|
|
- Comparable benchmarks cited
|
|
- Calculation and rationale
|
|
- Supporting documentation (appraisals, market analysis, etc.)
|
|
- Board approval and minutes
|
|
- Contemporaneous written documentation
|
|
```
|
|
|
|
## 7. Operational Separation Checklist
|
|
|
|
To maintain liability shields and transfer pricing defensibility:
|
|
|
|
- [ ] Separate articles of incorporation for each subsidiary
|
|
- [ ] Separate corporate bylaws and governance policies
|
|
- [ ] Distinct boards of directors (even if overlapping members)
|
|
- [ ] Separate bank accounts and financial books
|
|
- [ ] No commingling of funds or assets
|
|
- [ ] Formal intercompany agreements for all shared resources
|
|
- [ ] Separate tax returns filed annually
|
|
- [ ] Separate insurance policies and liability coverage
|
|
- [ ] Distinct letterhead, business cards, signage
|
|
- [ ] Independent accounting and financial reporting
|
|
- [ ] Transfer pricing documentation for all intercompany transactions
|
|
- [ ] Minutes documenting substantive board decisions
|
|
- [ ] No guarantees of sibling subsidiaries' obligations
|
|
|
|
**Risk**: Failure to maintain separation invites IRS "piercing the corporate veil," exposing parent company to subsidiary liabilities.
|
|
|
|
## 8. Foundation Governance (501(c)(3) Compliance)
|
|
|
|
### Fund Accounting
|
|
|
|
Foundation must use Fund Accounting (unlike for-profit accounting), separating resources into:
|
|
|
|
**Unrestricted Funds**: Available for any exempt purpose
|
|
**Restricted Funds**: Donor-designated (e.g., "for open-source only")
|
|
|
|
All transfers from Corp must be documented as grants/contributions with restrictions clearly noted.
|
|
|
|
### Related-Party Transaction Board Approval
|
|
|
|
Before any Corp transfer to Foundation:
|
|
|
|
1. Independent majority votes
|
|
2. Minority includes conflicted party vote counts documented
|
|
3. FMV analysis presented
|
|
4. Minutes record rationale and vote
|
|
5. Excess Benefit Transaction disclosure if applicable
|
|
|
|
### Annual Form 990 Reporting
|
|
|
|
Foundation must file IRS Form 990 disclosing:
|
|
|
|
- Compensation of officers/directors
|
|
- Related-party transactions
|
|
- All grants and contributions received
|
|
- Fund balances and restrictions
|
|
|
|
**Public Filing**: These forms are public, subject to IRS scrutiny.
|
|
|
|
## 9. Benefit Corporation Governance (Parent Level)
|
|
|
|
Parent company incorporated as Benefit Corporation (not C-Corp) specifically to:
|
|
|
|
- Balance shareholder profit with stakeholder interests
|
|
- Legally protect Foundation funding decisions
|
|
- Enable long-term R&D investment (Labs) even during fiscal pressure
|
|
- Align investor expectations with dual mission
|
|
|
|
### Board Duties
|
|
|
|
Benefit Corporation directors have legal duty to:
|
|
|
|
1. Consider impact on stakeholders (workers, customers, community)
|
|
2. Balance shareholder returns with general public benefit
|
|
3. Document consideration of non-shareholder interests in board minutes
|
|
|
|
This provides legal cover for capital allocation to Foundation or high-burn Labs research.
|
|
|
|
## 10. Private Inurement Prevention
|
|
|
|
### Definition
|
|
|
|
Private inurement = net earnings of Foundation inure to benefit of any shareholder/individual = immediate loss of 501(c)(3) status.
|
|
|
|
### High-Risk Transactions
|
|
|
|
1. **Over-Compensation**: Foundation paying executives above-market salaries = hidden private inurement
|
|
2. **Below-Market Services from Foundation**: Foundation providing services to Corp at cost (instead of FMV) = private inurement to Corp
|
|
3. **Related-Party Conflicts**: Foundation board dominated by Corp executives with financial interest in transactions
|
|
|
|
### Controls
|
|
|
|
- **Independent Board**: Clear majority of unaffiliated directors
|
|
- **FMV Documentation**: All transactions with related parties must show FMV (can withstand IRS audit)
|
|
- **Excess Benefit Transactions**: Must be prohibited and subject to correction procedures
|
|
- **Annual Certification**: Officers certify no private inurement annually
|
|
- **Form 990 Schedule**: Disclose all related-party transactions transparently
|
|
|
|
## 11. Transfer Pricing Documentation Requirements
|
|
|
|
### When Required
|
|
|
|
Any payment between related entities (Labs→Corp, Corp→Foundation, etc.) requires documentation.
|
|
|
|
### Documentation Package
|
|
|
|
1. **Intercompany Agreement**
|
|
|
|
- Parties, services/IP, payment terms, effective date
|
|
- Signed and dated
|
|
|
|
2. **Transfer Pricing Study**
|
|
|
|
- Executive summary
|
|
- Functional analysis (functions, assets, risks of each party)
|
|
- Economic analysis (industry data, market conditions)
|
|
- Comparable price analysis
|
|
- Selection and application of transfer pricing method
|
|
- Sensitivity analysis
|
|
- Conclusion re: Arm's Length pricing
|
|
|
|
3. **Contemporaneous Documentation**
|
|
- Prepared at time of transaction (or within 60 days of return filing)
|
|
- Supported by benchmarking analysis
|
|
- Updated annually if rates change
|
|
|
|
**IRS Penalty Risk**: Failure to maintain documentation = 20-40% penalty on underpayment, plus interest and potential accuracy penalties.
|
|
|
|
## 12. Annual Compliance Checklist
|
|
|
|
**Each Fiscal Year:**
|
|
|
|
- [ ] Review intercompany transfer pricing—update for current market rates
|
|
- [ ] Verify FMV for all related-party transactions
|
|
- [ ] Update transfer pricing study if material changes
|
|
- [ ] Confirm operational separation maintained (separate accounts, agreements, etc.)
|
|
- [ ] Foundation Form 990 filed on time with related-party disclosures
|
|
- [ ] Separate tax returns filed for each subsidiary
|
|
- [ ] Conflict of Interest certifications renewed
|
|
- [ ] Board minutes document transfer pricing compliance review
|
|
- [ ] Fund Accounting records reviewed for restriction compliance
|
|
- [ ] Royalty/license payments reconciled and properly documented
|
|
- [ ] IP ownership and licensing agreements current
|
|
|
|
## 13. Key Documents Template Checklist
|
|
|
|
Maintain and update:
|
|
|
|
- [ ] **Intercompany Technology License Agreement** (Labs→Corp, Labs→Dev-Link)
|
|
- [ ] **Intercompany Service Agreement** (shared services pricing)
|
|
- [ ] **Grant Agreement** (Corp→Foundation donations)
|
|
- [ ] **Conflict of Interest Policy** (Foundation board)
|
|
- [ ] **Related-Party Transaction Policy** (approval procedures)
|
|
- [ ] **Transfer Pricing Study** (FMV methodology)
|
|
- [ ] **Fund Accounting Manual** (Foundation accounting standards)
|
|
- [ ] **Operational Separation Documentation** (evidence of corporate veil maintenance)
|
|
- [ ] **Annual Compliance Checklist** (governance review)
|
|
|
|
## Conclusion
|
|
|
|
This framework ensures:
|
|
|
|
1. **IP Protection**: Centralized control and defensive valuation
|
|
2. **Tax Compliance**: Arm's Length transfer pricing reduces audit risk
|
|
3. **Liability Insulation**: Separate entities prevent cross-contamination
|
|
4. **Tax-Exempt Status**: Related-party safeguards preserve Foundation 501(c)(3)
|
|
5. **Investor Confidence**: Clear governance and discipline in capital allocation
|
|
|
|
All executives must understand and comply with these requirements. Non-compliance carries significant IRS penalties, potential loss of tax-exempt status, and personal liability for directors/officers.
|
|
|
|
---
|
|
|
|
**Last Updated:** December 2024
|
|
**Owner:** General Counsel / Finance
|
|
**Review Frequency:** Annual (or upon material change)
|
|
**Distribution:** Board of Directors, CFO, Foundation Treasurer, Subsidiary Officers
|